The way companies innovate is broken.
The systems built to create and protect ideas can’t keep up with the pace of change.
Today, 90% of S&P 500 company value is intangible (e.
, in intellectual property) - yet R&D and IP teams spend half their time buried in manual work, sifting through patents and paperwork instead of pushing the frontier forward.
The tools of creating and protecting are stuck in the past.
We’re here to fix that.
Ankar is building the R&D tools for the AI era and defining what applied research will look like in the next 20 years.
We’re building infrastructure and product experiences our customers rely on every day.
You’ll translate messy, ambiguous problems into clean, dependable software—and you’ll do it at the cutting-edge of AI.
We’re at an inflection point:We’ve raised >$24M to date from Tier-1 VCs like Atomico, Index Ventures, Norrsken, Daphni, and angels like the Founder of Hugging Face, CEO from Datadog, and Leaders from DeepMind and OpenAI.
We’re already working with the world’s most innovative companies including Fortune 500 company L’Oréal and global law firm VorysExpanding our world-class team with alumni from Palantir, Amazon, and BCG to tackle the $1T+ innovation market.
We’re just getting started.
What you’ll be doingWe’re looking for a patent professional with deep large-molecule life sciences expertise who can bridge product development, engineering and IP protection.
You’ll work hands-on with pharmaceutical and biotech customers to design AI-powered patent solutions that understand the nuances of biologics—including antibodies, proteins, peptides, nucleic acids, vaccines and cell and gene therapies—and the conventions that govern their patent protection.
Build life sciences-specific patent products: Partner with product and engineering teams to develop AI tools tailored to large-molecule patents—from protein and antibody sequence analysis to biologics claim generation, sequence-listing support and prior-art searching across life sc.